Sentences with phrase «pharmaceutical market sectors»

Not exact matches

The guidelines rejected the possibility of full access to the EU's single market for crucial U.K. sectors such as finance and pharmaceuticals, stating there can be no «cherry picking» through participation based on a sector - by - sector approach.

I remember one day about 13 years ago, when I was a daytrader, I immediately noticed relative strength in the pharmaceutical sector ($ DRG) shortly after the market opened.

The iShares ETF is the largest covering the sector, tracking a set of biotechnology and pharmaceutical stocks that trade on the Nasdaq stock market.

Food and Beverages are the largest sectors in the Italian packaging market, followed by Health & Beauty and Pharmaceuticals.

Key Features: • Focuses on health claim legislation for this commercially important food sector • Includes chapters on the current situation in all the major world markets including Europe, the USA, Japan, India and China • Covers food, feed and pharmaceutical applications of probiotics

Founded in 1974 Co.Plast S.r.l. operates in the sector of injection moulded plastic material producing a wide range of high quality closures for the pharmaceutical, cosmetic, and household markets.

Every sector of the pharmaceutical market is represented under one roof, this year in Frankfurt.

We are a crucial — profitable — export market for Europe's automotive industry, as well as sectors including energy, food and drink, chemicals, pharmaceuticals, and agriculture.

They are indexed into sectors such as sales and marketing, management consulting, and pharmaceuticals.

Now a $ 60 billion market for the biotechnology and pharmaceutical sectors, growth of the market has been hampered by high development costs of producing these in animal cell systems, which when factoring in a long period for manufacturing, R&D and clinical trials, may reach around $ 1 billion per each therapeutic candidate.

Professor Hayday added: «This is very significant because antibodies make up one of the largest sectors of the pharmaceutical market, and one of the great quests in the pharmaceutical industry is to be able to routinely generate antibodies against human proteins implicated in diseases.

For example, I'm considering buying funds invested in the Biotech, Software / IT, Retailing, Pharmaceuticals, and Chemicals sectors of the market, which have outperformed the typical 7 % average annual return of a typical «all stocks all sectors» portfolio.

The U.S. market in particular offers a wealth of sectors that are minimal or non-existent in Canada: high - tech, pharmaceuticals and bio-tech, defence stocks, social media stocks and many more.

Back when the Canadian dollar was trading roughly at par with the U.S. dollar (and briefly above it), it was a great opportunity for Canadian investors to diversify outside of the Canadian equity market to buy world - class U.S. stocks in sectors underrepresented in Canada: technology, health care, pharmaceuticals, consumer staples and the like.

Mutual funds and ETFs are entities which invest into asset classes / sectors / regions (e.g. equities / bonds, financials / pharmaceuticals, emerging markets / Europe) and then divide ownership of themselves into shares which are held by shareholders.

It is seen quite often that the stock of a particular sector (say, IT or pharmaceuticals) outweigh the overall market index.

«The pharmaceutical, life sciences and technology markets in New Jersey, New York and Pennsylvania are strategic priorities for the firm, and the additions of Andrew and Michael bolster the firm's capabilities to address the constantly increasing needs of clients in these sectors.»

This is so because any undertaking active in the pharmaceutical sector is familiar with the fact that preparation for the production of generic versions of drugs commences many years before the expiry of an original patent, and that the expiry itself triggers an intense race in order to be the first to enter the market.

EEA's newest members represent a wide variety of business sectors, including technology, banking, government, healthcare, energy, pharmaceuticals, marketing, and insurance, as well as a number of fast - growing Ethereum startups.Composed of forward - looking enterprises and blockchain innovators, EEA is an industry - supported, non-profit established to build, promote, and broadly support Ethereum - based technology best practices, open standards, and open source reference architectures.

EEA's membership represents a wide variety of business sectors from every region of the world, including technology, banking, government, healthcare, energy, pharmaceuticals, marketing, logistics and insurance.

EEA's membership represents a wide variety of business sectors from every region of the world, including technology, banking, government, healthcare, energy, pharmaceuticals, marketing, and insurance, as well as a number of fast - growing Ethereum startups.

According to the consortium, which focuses on developments on the Ethereum blockchain, the newest members of EEA represent a «wide variety of business sectors, including technology, banking, government, healthcare, energy, pharmaceuticals, marketing, and insurance, as well as a number of fast - growing Ethereum startups.»

Hays Life Sciences is a market leader in filling jobs across the pharmaceutical and medical device sectors.

Updated the Senior Analyst, also a contributing author to Forbes magazine, about recent events in the healthcare sector, such as the Ebola outbreak, and the market trend of biotech / pharmaceutical companies

Pharmacy graduates are also employed by private sector organisations, e.g. pharmaceutical companies and food and drink companies, to work in areas such as research and development, quality assurance, marketing, sales and management.

SUMMARY * A seasoned, full - spectrum Business / Process Analyst & Project / Change Manager with a 25 - year proven track record across multiple industries: healthcare, pharmaceutical, financial, utilities, broadcasting, B2B, IT, telecommunications, real estate, marketing / sales, and public sectors * Strong leadership, with full project lifecycle and ample organizational experience * Results - orientated, client - facing, and quality - fo...

Summary Dynamic Pharmaceutical Key Account Manager with ten years of experience in the pharmaceutical sector with in - depth knowledge of European and American Market thanks to a U.S Master Degree in Health Administration.